Long-term probability of intraocular pressure elevation with the intravitreal dexamethasone implant in the real-world.

Javier Zarranz-VenturaAnna Sala-PuigdollersDaniel Velázquez-VilloriaMarc Figueras-RocaSergio CopeteLaura DistefanoAnna BoixaderaJose García-ArumiAlfredo Adannull null

Published in: PloS one (2019)

In the long-term (24 months), IOP elevation is common, generally mild (30% IOP, ≥25 mmHg) and well-tolerated, resolving with topical treatment (54%) and rarely requiring surgery (0.9%).

Keyphrases

minimally invasive
coronary artery bypass
low dose
high dose
acute coronary syndrome
age related macular degeneration
atrial fibrillation
replacement therapy